title: Synthesis, characterization and bactericidal activity of silica/silver core-shell nanoparticles.
abstract: Silica/silver core-shell nanoparticles (NPs) were synthesized by coating silver NPs on silica core particles (size ~300 ± 10 nm) via electro less reduction method. The core-shell NPs were characterized for their structural, morphological, compositional and optical behavior using X-ray diffraction, scanning electron microscopy, energy dispersive X-ray analysis and UV-Visible spectroscopy, respectively. The size (16-35 nm) and loaded amount of silver NPs on the silica core were found to be dependent upon reaction time and activation method of silica. The bactericidal activity of the NPs was tested by broth micro dilution method against both Bacillus subtilis (gram positive) and Escherichia coli ATCC25922 (gram negative) bacterium. The bactericidal activity of silica/silver core-shell NPS is more against E. coli ATCC25922, when compared to B. subtilis. The minimal inhibitory concentration of the core-shell NPs ranged from 7.8 to 250 μg/mL and is found to be dependent upon the amount of silver on silica, the core. These results suggest that silica/silver core-shell NPs can be utilized as a strong substitutional candidate to control pathogenic bacterium, which are otherwise resistant to antibiotics, making them applicable in diverse medical devices.
authors: Academy of Scientific and Innovative Research, Central Scientific Instruments Organisation, Sector 30 C, Chandigarh, 160030, India.
authors: Pooja
authors: P
authors: Devi
authors: Supriya Deepak
authors: SD
authors: Patil
authors: P
authors: P
authors: Jeevanandam
authors: Naveen K
authors: NK
authors: Navani
authors: M L
authors: ML
authors: Singla
mesh_terms: D065966:Absorption, Physicochemical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D018407:Bacterial Physiological Phenomena / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004058:Diffusion; D008422:Materials Testing; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry* / Q000648:ultrastructure; D012822:Silicon Dioxide / Q000737:chemistry*; D012834:Silver / Q000008:administration & dosage* / Q000737:chemistry*
chemical_list: D000900:Anti-Bacterial Agents; D053769:Nanocapsules; D012834:Silver; D012822:Silicon Dioxide